hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_09647.1
Complex Portal: CPX-21667
Confidence: Moderate High
Proteins| Genename | Protein Name | Uniprot Annotation Score | Links |
|---|---|---|---|
| IFNA7 | Interferon alpha-7 (IFN-alpha-7) (Interferon alpha-J) (LeIF J) (Interferon alpha-J1) (IFN-alpha-J1) | 5 | UniProt NCBI |
| IFNA6 | Interferon alpha-6 (IFN-alpha-6) (Interferon alpha-54) (Interferon alpha-K) (LeIF K) | 5 | UniProt NCBI |
| ISG15 | Ubiquitin-like protein ISG15 (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein) (hUCRP) | 5 | UniProt NCBI |
| IFNA16 | Interferon alpha-16 (IFN-alpha-16) (Interferon alpha-WA) | 4 | UniProt NCBI |
| IFNA2 | Interferon alpha-2 (IFN-alpha-2) (Interferon alpha-A) (LeIF A) | 5 | UniProt NCBI |
| UBA7 | Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (EC 6.2.1.-) (D8) (Ubiquitin-activating enzyme E1 homolog) | 5 | UniProt NCBI |
| UBR3 | E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650) | 5 | UniProt NCBI |
| IFNA4 | Interferon alpha-4 (IFN-alpha-4) (Interferon alpha-4B) (Interferon alpha-76) (Interferon alpha-M1) | 5 | UniProt NCBI |
Enrichments
| Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
|---|---|---|---|---|
| REAC:R-HSA-168928 | 1.19235558449e-13 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | DDX58/IFIH1-mediated induction of interferon-alpha/beta |
| KEGG:04622 | 8.40919126205e-12 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | RIG-I-like receptor signaling pathway |
| WP:WP4655 | 1.54986919246e-11 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | Cytosolic DNA sensing pathway |
| REAC:R-HSA-909733 | 2.43069005585e-11 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | Interferon alpha/beta signaling |
| REAC:R-HSA-913531 | 5.27382436195e-11 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | Interferon Signaling |
| REAC:R-HSA-912694 | 7.19794090728e-11 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Regulation of IFNA/IFNB signaling |
| WP:WP4912 | 1.30567693934e-10 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | SARS coronavirus and innate immunity |
| REAC:R-HSA-933541 | 2.53770772028e-10 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | TRAF6 mediated IRF7 activation |
| WP:WP4558 | 2.97181496942e-10 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Overview of interferons mediated signaling pathway |
| KEGG:05320 | 3.26549145553e-10 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Autoimmune thyroid disease |
| REAC:R-HSA-9705671 | 1.04102727567e-09 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | SARS-CoV-2 activates/modulates innate and adaptive immune responses |
| GO:0005132 | 2.198402683e-09 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | type I interferon receptor binding |
| GO:0033141 | 4.31077484224e-09 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| KEGG:05169 | 4.36130819142e-09 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | Epstein-Barr virus infection |
| GO:0033139 | 5.84933550117e-09 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | regulation of peptidyl-serine phosphorylation of STAT protein |
| KEGG:04623 | 5.97551490727e-09 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Cytosolic DNA-sensing pathway |
| GO:0060337 | 7.71019557823e-09 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | type I interferon-mediated signaling pathway |
| GO:0042501 | 7.79777844544e-09 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | serine phosphorylation of STAT protein |
| GO:0071357 | 8.49328317467e-09 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | cellular response to type I interferon |
| KEGG:05171 | 8.76952216946e-09 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | Coronavirus disease - COVID-19 |
| GO:0034340 | 1.3474149637e-08 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | response to type I interferon |
| KEGG:04620 | 1.81897246823e-08 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Toll-like receptor signaling pathway |
| GO:0002323 | 2.13628596361e-08 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | natural killer cell activation involved in immune response |
| REAC:R-HSA-9705683 | 2.43973068451e-08 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | SARS-CoV-2-host interactions |
| WP:WP75 | 2.63612217757e-08 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Toll like receptor signaling pathway |
| WP:WP5095 | 2.80248370233e-08 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Overview of proinflammatory and profibrotic mediators |
| GO:0140888 | 4.48653214139e-08 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | interferon-mediated signaling pathway |
| KEGG:04650 | 5.72951789473e-08 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Natural killer cell mediated cytotoxicity |
| KEGG:05165 | 8.44201073345e-08 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | Human papillomavirus infection |
| KEGG:04936 | 1.10133799407e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Alcoholic liver disease |
| KEGG:05162 | 1.10133799407e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Measles |
| KEGG:05160 | 1.45399109258e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Hepatitis C |
| KEGG:04630 | 1.45399109258e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | JAK-STAT signaling pathway |
| GO:0043330 | 1.62855460324e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | response to exogenous dsRNA |
| KEGG:04217 | 1.82324215305e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Necroptosis |
| WP:WP4630 | 1.94832547338e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Measles virus infection |
| REAC:R-HSA-9694516 | 2.32248024129e-07 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | SARS-CoV-2 Infection |
| KEGG:05164 | 2.34479372129e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Influenza A |
| KEGG:04621 | 2.51378764444e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | NOD-like receptor signaling pathway |
| KEGG:05152 | 2.51378764444e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Tuberculosis |
| KEGG:05161 | 2.69236213749e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Hepatitis B |
| GO:0043331 | 2.88637288207e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | response to dsRNA |
| WP:WP4666 | 3.36035506311e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Hepatitis B infection |
| REAC:R-HSA-1280215 | 3.46231656991e-07 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | Cytokine Signaling in Immune system |
| KEGG:05167 | 5.09840115343e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Kaposi sarcoma-associated herpesvirus infection |
| KEGG:05417 | 7.21279918769e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Lipid and atherosclerosis |
| KEGG:05163 | 9.97423580158e-07 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Human cytomegalovirus infection |
| KEGG:05170 | 1.02377381044e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Human immunodeficiency virus 1 infection |
| KEGG:04060 | 1.13478166657e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Cytokine-cytokine receptor interaction |
| REAC:R-HSA-983231 | 1.55818303132e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Factors involved in megakaryocyte development and platelet production |
| REAC:R-HSA-9679506 | 1.58989951654e-06 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | SARS-CoV Infections |
| GO:0098586 | 1.73918590284e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | cellular response to virus |
| GO:0042100 | 1.9093666652e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | B cell proliferation |
| GO:0030101 | 3.8059460675e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | natural killer cell activation |
| REAC:R-HSA-168249 | 4.82030755338e-06 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | Innate Immune System |
| GO:0033138 | 6.03527005634e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | positive regulation of peptidyl-serine phosphorylation |
| GO:0046425 | 6.49137262244e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | regulation of receptor signaling pathway via JAK-STAT |
| KEGG:04151 | 7.32253759805e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | PI3K-Akt signaling pathway |
| GO:1904892 | 8.59915280573e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | regulation of receptor signaling pathway via STAT |
| GO:0002286 | 9.20314592393e-06 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | T cell activation involved in immune response |
| WP:WP4172 | 1.03157414074e-05 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | PI3K Akt signaling pathway |
| GO:0030183 | 1.35780446837e-05 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | B cell differentiation |
| GO:0033135 | 2.18404921906e-05 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | regulation of peptidyl-serine phosphorylation |
| KEGG:05168 | 2.5317407689e-05 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Herpes simplex virus 1 infection |
| GO:0045087 | 4.03783814262e-05 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | innate immune response |
| GO:0009615 | 6.22126526225e-05 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | response to virus |
| KEGG:05200 | 6.65080913942e-05 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Pathways in cancer |
| REAC:R-HSA-9824446 | 6.65123357146e-05 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | Viral Infection Pathways |
| GO:0007259 | 7.26529922203e-05 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | receptor signaling pathway via JAK-STAT |
| GO:0097696 | 8.65298625156e-05 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | receptor signaling pathway via STAT |
| GO:0002285 | 9.42197559575e-05 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | lymphocyte activation involved in immune response |
| GO:0140546 | 0.000139795561249 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | defense response to symbiont |
| GO:0005125 | 0.000152608422189 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | cytokine activity |
| GO:0019221 | 0.000170744030661 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | cytokine-mediated signaling pathway |
| REAC:R-HSA-5663205 | 0.000225631247355 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | Infectious disease |
| GO:0042113 | 0.000228640520871 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | B cell activation |
| GO:0098542 | 0.000237865963031 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | defense response to other organism |
| GO:0046651 | 0.000311066050549 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | lymphocyte proliferation |
| GO:0032943 | 0.000343267329535 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | mononuclear cell proliferation |
| GO:0002366 | 0.000402802229143 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | leukocyte activation involved in immune response |
| REAC:R-HSA-168256 | 0.000413385725657 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | Immune System |
| GO:0005126 | 0.00045612716804 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | cytokine receptor binding |
| GO:0002263 | 0.00045612716804 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | cell activation involved in immune response |
| GO:0006959 | 0.00049969922276 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | humoral immune response |
| GO:0018105 | 0.000530546258616 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | peptidyl-serine phosphorylation |
| GO:0070661 | 0.00056289357035 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | leukocyte proliferation |
| REAC:R-HSA-109582 | 0.000639290175941 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Hemostasis |
| GO:0018209 | 0.000728492717957 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | peptidyl-serine modification |
| GO:0051707 | 0.000788366098329 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | response to other organism |
| GO:0043207 | 0.000788366098329 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | response to external biotic stimulus |
| GO:0071345 | 0.000858141370388 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | cellular response to cytokine stimulus |
| GO:0009607 | 0.000990020309543 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | response to biotic stimulus |
| GO:0002250 | 0.00133227426114 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | adaptive immune response |
| GO:0034097 | 0.00173515196987 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | response to cytokine |
| GO:0044419 | 0.00196376711866 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | biological process involved in interspecies interaction between organisms |
| GO:0030098 | 0.00277332542848 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | lymphocyte differentiation |
| GO:0006952 | 0.00289253162341 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | defense response |
| GO:0006955 | 0.00320293753229 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | immune response |
| GO:1903131 | 0.00496080448558 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | mononuclear cell differentiation |
| REAC:R-HSA-1643685 | 0.00541892543827 | 0.75 | IFNA16 IFNA6 IFNA4 IFNA7 IFNA2 ISG15 | Disease |
| GO:0048018 | 0.00544786385004 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | receptor ligand activity |
| GO:0030546 | 0.00586429352642 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | signaling receptor activator activity |
| TF:M08500 | 0.00610957850275 | 0.375 | IFNA7 IFNA4 IFNA2 | Factor: HOXB2:ETV7; motif: TAATGRNSMGGAARYRCTTCCGS |
| GO:0036211 | 0.00785011818004 | 1.0 | UBA7 IFNA16 IFNA6 UBR3 IFNA7 IFNA4 IFNA2 ISG15 | protein modification process |
| WP:WP619 | 0.00833957037235 | 0.25 | ISG15 IFNA2 | Type II interferon signaling |
| GO:0030545 | 0.00848600338175 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | signaling receptor regulator activity |
| GO:0042110 | 0.0115920123448 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | T cell activation |
| TF:M04238_1 | 0.0142611443327 | 0.5 | IFNA6 IFNA16 IFNA4 IFNA2 | Factor: FOXD2; motif: NRNWAATATTTAYN; match class: 1 |
| GO:0043412 | 0.015172830196 | 1.0 | UBA7 IFNA16 IFNA6 UBR3 IFNA7 IFNA4 IFNA2 ISG15 | macromolecule modification |
| GO:0002521 | 0.0182752627698 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | leukocyte differentiation |
| GO:0014070 | 0.0204934010898 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | response to organic cyclic compound |
| GO:0002252 | 0.0229204338906 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | immune effector process |
| REAC:R-HSA-5656169 | 0.0257351328695 | 0.25 | UBA7 ISG15 | Termination of translesion DNA synthesis |
| TF:M03575 | 0.0259182699043 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | Factor: HEN2; motif: CATYTGNNN |
| REAC:R-HSA-936440 | 0.02920582473 | 0.25 | UBA7 ISG15 | Negative regulators of DDX58/IFIH1 signaling |
| GO:0001934 | 0.0382298956043 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | positive regulation of protein phosphorylation |
| REAC:R-HSA-110313 | 0.0388325640363 | 0.25 | UBA7 ISG15 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template |
| GO:0009605 | 0.0411970326794 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | response to external stimulus |
| GO:0002376 | 0.0453835709162 | 0.875 | UBA7 IFNA16 IFNA6 IFNA7 IFNA4 IFNA2 ISG15 | immune system process |
| WP:WP4341 | 0.0459468228145 | 0.25 | ISG15 IFNA2 | Non genomic actions of 1 25 dihydroxyvitamin D3 |
| GO:0042327 | 0.0493189200251 | 0.625 | IFNA6 IFNA2 IFNA7 IFNA4 IFNA16 | positive regulation of phosphorylation |
Edges
| Protein 1 | Protein 2 | Score | ProteomeHD | Interface Overlap | Evidence |
|---|---|---|---|---|---|
| IFNA7 | IFNA4 | 0.995 |
structurally_consistent (dimer)
|
bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM | |
| ISG15 | UBA7 | 0.993 | 0.134 |
structurally_consistent (dimer)
|
bioplex3_HEK293 bioplex3_WMM bioplex3_HCT116 WMM_only |
| IFNA2 | IFNA4 | 0.992 |
structurally_consistent (P01569)
structurally_consistent (dimer) |
bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM | |
| ISG15 | IFNA4 | 0.992 | bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116 | ||
| IFNA2 | ISG15 | 0.989 |
mutually_exclusive (P01569)
|
bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116 | |
| IFNA7 | IFNA16 | 0.989 | bioplex3_HEK293 bioplex3_WMM WMM_only | ||
| IFNA7 | ISG15 | 0.987 |
structurally_consistent (dimer)
|
bioplex3_HEK293 bioplex_WMM bioplex3_WMM bioplex3_HCT116 WMM_only | |
| IFNA6 | ISG15 | 0.986 |
mutually_exclusive (P01569)
|
bioplex_WMM bioplex3_WMM bioplex3_HCT116 WMM_only | |
| ISG15 | IFNA16 | 0.982 | bioplex3_HEK293 bioplex_WMM bioplex3_WMM WMM_only | ||
| IFNA7 | UBR3 | 0.978 | bioplex3_HEK293 bioplex3_WMM bioplex3_HCT116 WMM_only | ||
| IFNA6 | IFNA4 | 0.97 | bioplex_WMM bioplex3_WMM WMM_only | ||
| ISG15 | UBR3 | 0.966 | 0.098 | bioplex_WMM bioplex3_WMM WMM_only | |
| IFNA16 | UBR3 | 0.925 | bioplex3_HEK293 bioplex_WMM bioplex3_WMM WMM_only | ||
| IFNA6 | UBR3 | 0.612 | bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116 | ||
| IFNA2 | IFNA7 | 0.502 |
mutually_exclusive (P05014)
|
bioplex_WMM bioplex3_WMM WMM_only | |
| IFNA6 | IFNA16 | 0.333 |
mutually_exclusive (P01569)
|
bioplex_WMM bioplex3_WMM WMM_only | |
| IFNA4 | IFNA16 | 0.333 | bioplex_WMM bioplex3_WMM WMM_only | ||
| IFNA2 | UBR3 | 0.226 | bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116 | ||
| IFNA4 | UBR3 | 0.13 | bioplex_WMM bioplex3_WMM WMM_only |
Related Complexes